Nippon Paper Begins Test Farming Rice That Alleviates Hay Fever
Main Category: AllergyAlso Included In: Nutrition / Diet; Immune System / Vaccines
Article Date: 10 Sep 2006 - 0:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
5 (3 votes) |
| Healthcare Prof: |  |
Nippon Paper Group has started test farming a rice which could alleviate hay-fever symptoms. The rice was specially developed using the MAT vector system, a biotechnology for genetically extracting certain genomes, in this case an epitope in the rice. The epitope will act as a vaccine for hay-fever, so people who eat it will experience fewer hay-fever symptoms when the season arrives.
Nippon Paper will set up a large greenhouse of 500 square meters on the island of Komatsu. With proper light and temperature control, the greenhouse will yield 700 kilograms of rice annually.
The project was commissioned by the Ministry of Agriculture, Forestry, and Fisheries.
By Chris Lui, JCN Staff Writer
Copyright © 2006 JCN. All rights reserved. A division of Japan Corporate News Network KK.
JCN
Visit our allergy section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/51518.php>
APA
http://www.medicalnewstoday.com/releases/51518.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
